A third-generation CAR constructs with the NK-cell-activating molecules 2B4 and DNAM-1 displayed greater cytotoxicity against hepatocellular cancer cells expressing GPC3 compared to CAR with only CD3ζ or CD28-CD3ζ [112]. Here, CD247 is linked to hepatocellular carcinoma.